Literature DB >> 25373346

Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.

Yuewen Chao1, Yan Wang, Xuejiao Liu, Peng Ma, Yi Shi, Jian Gao, Qiong Shi, Jinxia Hu, Rutong Yu, Xiuping Zhou.   

Abstract

Mammalian sterile 20-like 1 (Mst1), an upstream serine/threonine-specific protein kinase of the Hippo pathway, is reported to play important roles in tumor suppression and organ size regulation in mammals via regulating cell proliferation and survival. However, whether it is involved in the pathogenesis of malignant gliomas remains poorly understood. Therefore, in the present work, we examined the effect and mechanism of Mst1 on the proliferation and apoptosis of malignant glioma cells. The cell proliferation and growth of glioma cells were examined by EdU incorporation and CCK-8 assay. In addition, the cell apoptosis was assessed by flow cytometry. We found that down-regulation of Mst1 promoted glioma cell proliferation and growth, but inhibited the cell apoptosis. Consistent with this, over-expression of Mst1 inhibited glioma cell proliferation and growth. Interestingly, Mst1 did not affect the phosphorylation of YAP1, the key downstream molecule of Hippo pathway. However, Mst1 was found to bind to AKT in glioma cell and negatively regulated AKT and mTOR activity. Finally, the increased cell proliferation rate induced by Mst1 down-regulation was partially abolished by down-regulation of AKT1. Meanwhile, glioma cell growth inhibition induced by Mst1 over-expression was partially rescued by over-expression of AKT1. Taken together, these findings suggest that Mst1 regulates proliferation of glioma cells via AKT/mTOR signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25373346     DOI: 10.1007/s11060-014-1654-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  43 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Authors:  Stuart A Grossman; Xiaobu Ye; Steven Piantadosi; Serena Desideri; Louis B Nabors; Myrna Rosenfeld; Joy Fisher
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

3.  Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

Authors:  Stefano Piccolo; Michelangelo Cordenonsi; Sirio Dupont
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

Review 4.  The Akt-mTOR tango and its relevance to cancer.

Authors:  Nissim Hay
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

5.  Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.

Authors:  Wesley M Konsavage; Sydney L Kyler; Sherri A Rennoll; Ge Jin; Gregory S Yochum
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

Review 6.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

7.  Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells.

Authors:  Aixia Ren; Guijun Yan; Bei You; Jianxin Sun
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

8.  The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells.

Authors:  Soon Young Shin; Kyoung Sun Lee; Yang-Kyu Choi; Hyunjung Jade Lim; Hong Ghi Lee; Yoongho Lim; Young Han Lee
Journal:  Carcinogenesis       Date:  2013-05-20       Impact factor: 4.944

9.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

Review 10.  mTOR signaling in glioblastoma: lessons learned from bench to bedside.

Authors:  David Akhavan; Timothy F Cloughesy; Paul S Mischel
Journal:  Neuro Oncol       Date:  2010-05-14       Impact factor: 12.300

View more
  28 in total

Review 1.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

2.  Exploration of MST1-Mediated Secondary Brain Injury Induced by Intracerebral Hemorrhage in Rats via Hippo Signaling Pathway.

Authors:  Peng Zhang; Tianyi Wang; Dongping Zhang; Zhuwei Zhang; Shuai Yuan; Juyi Zhang; Jie Cao; Haiying Li; Xiang Li; Haitao Shen; Gang Chen
Journal:  Transl Stroke Res       Date:  2019-04-02       Impact factor: 6.829

3.  Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.

Authors:  Mei Liu; Yong Lin; Xian-Chao Zhang; Yu-Huan Tan; Yue-Liang Yao; Juan Tan; Xia Zhang; You-Hong Cui; Xindong Liu; Yan Wang; Xiu-Wu Bian
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

4.  CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment.

Authors:  Guobin Zhang; Yunsheng Zhang; Sen Cheng; Zhen Wu; Fusheng Liu; Junting Zhang
Journal:  J Neurooncol       Date:  2017-09-25       Impact factor: 4.130

5.  HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer.

Authors:  Fei Li; Mingqiang Su; Hongfan Zhao; Weiwei Xie; Sai Cao; Ying Xu; Weihong Chen; Lili Wang; Lina Hou; Wanlong Tan
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

6.  LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.

Authors:  Yi Shi; Decheng Geng; Yu Zhang; Min Zhao; Yan Wang; Yang Jiang; Rutong Yu; Xiuping Zhou
Journal:  J Mol Neurosci       Date:  2019-02-15       Impact factor: 3.444

7.  Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.

Authors:  Tatiana V Kudryashova; Swati Dabral; Soni S Pullamsetti; Elena A Goncharova; Sreenath Nayakanti; Arnab Ray; Dmitry A Goncharov; Theodore Avolio; Yuanjun Shen; Analise Rode; Andressa Pena; Lifeng Jiang; Derek Lin; Jeffrey Baust; Timothy N Bachman; Johannes Graumann; Clemens Ruppert; Andreas Guenther; Mario Schmoranzer; Yann Grobs; Sarah Eve Lemay; Eve Tremblay; Sandra Breuils-Bonnet; Olivier Boucherat; Ana L Mora; Horace DeLisser; Jing Zhao; Yutong Zhao; Sébastien Bonnet; Werner Seeger
Journal:  Circ Res       Date:  2022-02-07       Impact factor: 17.367

8.  Icariside II induces cell cycle arrest and apoptosis in human glioblastoma cells through suppressing Akt activation and potentiating FOXO3a activity.

Authors:  Kai Quan; Xin Zhang; Kun Fan; Peixi Liu; Qi Yue; Bo Li; Jinfeng Wu; Baojun Liu; Yang Xu; Wei Hua; Wei Zhu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

9.  Expression and significance of Hippo/YAP signaling in glioma progression.

Authors:  Hao Zhang; Decheng Geng; Jian Gao; Yanhua Qi; Yi Shi; Yan Wang; Yang Jiang; Yu Zhang; Jiale Fu; Yu Dong; Shangfeng Gao; Rutong Yu; Xiuping Zhou
Journal:  Tumour Biol       Date:  2016-10-07

Review 10.  Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior.

Authors:  Benjamin J van Soldt; Wellington V Cardoso
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.